Atlas Trials

Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Clinical trial NCT04054167 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04054167
Sponsor
M.D. Anderson Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Mantle Cell LymphomaRefractory Mantle Cell Lymphoma
Start date
2019-06-14
Primary completion
2027-12-31
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.